Who is sponsoring CREATES?

CREATES is sponsored by RWTH Aachen University.

What drugs are being tested in CREATES?

Interventions: Spiolto® Respimat® (Tiotropium / Olodaterol).

What is the status of CREATES?

CREATES is currently WITHDRAWN.

Last reviewed 2022-10-25 · How we verify

Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD (CREATES)

NCT02812862 Phase 4 WITHDRAWN

The aim of this study is to evaluate the pulmonary and cardiac effects of the LABA / LAMA combination Tiotropium / Olodaterol therapy in patients suffering from both congestive heart failure and chronic obstructive pulmonary disease.

Details

Lead sponsor	RWTH Aachen University
Phase	Phase 4
Status	WITHDRAWN
Start date	2016-08
Completion	2018-08

Conditions

COPD

Interventions

Spiolto® Respimat® (Tiotropium / Olodaterol)

Primary outcomes

To examine the change in Residual Volume (RV) V0-V2 — 24 months

Countries

Germany